1. Product Responsibility and Patient Welfare

   - Safety and Efficacy: As a company focused on the promotion of targeted therapies, ensuring the safety and efficacy of its drugs is at the core of its corporate social responsibility. The company collaborates with pharmaceutical manufacturers and adheres to the highest international drug regulatory standards to ensure patient safety.

   - Affordability of Products: The company strives to improve the affordability of its drugs by reducing costs and partnering with renowned institutions, ensuring that more patients can benefit from its products.

 

2. Corporate Responsibility and Social Contributions

   - Medical Support and Charity: As a pharmaceutical company, Dawn Drugs supports vulnerable groups through drug donations, social welfare programs, and voluntary aid to meet the living needs of disadvantaged populations.

   - Education and Awareness: The company organizes educational activities to spread awareness about targeted therapies and related medical knowledge to the public, enhancing societal understanding of new medications and their potential benefits.

 

3. Ethical Standards and Transparency

   - R&D Transparency and Compliance: During drug production, the company maintains a high level of transparency, ensuring that all production activities adhere to the highest ethical standards and legal requirements. It also provides comprehensive certifications and test reports that meet international standards.

 

   - Data Protection and Privacy: When collaborating and communicating with patients, the company ensures the protection of personal data, safeguarding patient privacy in compliance with relevant privacy regulations.

 

By practicing these corporate social responsibilities, the company not only creates value for society and provides public services to the general population but also establishes a responsible and accountable corporate image, thereby building a positive reputation in the market.

 

                                                                               2024 Company Charity and Social Activitie